Home> Industry Information> China Top 10 Human Anti Rabies Vaccine Brands

China Top 10 Human Anti Rabies Vaccine Brands

August 03, 2024

China Top 10 Human Anti Rabies Vaccine Brands
The global human anti-Rabies Vaccine market is expected to witness significant growth due to increasing awareness about Rabies Prevention, rising incidence of rabies cases, and government initiatives for mass vaccination programs. Technological advancements in vaccine production and distribution are also driving market growth.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 1994

website : www.tianyuanbio.com

Main Product : Heparin Sodium, Enoxaparin Sodium, Hyaluronic Acid

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a renowned biopharmaceutical company specializing in the production of heparin products, enoxaparin sodium, and hyaluronic acid. With a strong emphasis on innovation and quality, the company has established itself as a key player in the global market, serving customers in various industries such as pharmaceuticals, healthcare, and cosmetics.

Liaoning Chengda Biotechnology Co., Ltd.

Establishment time : 1998

website : www.lncd.com

Main Product : Probiotics, enzymes, feed additives

Company Profile

Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of probiotics, enzymes, and feed additives. Established in 1998, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and the Middle East. With a medium-sized company size, Liaoning Chengda Biotechnology faces strong competition in the market from both domestic and international competitors. Visit their website at www.lncd.com for more information.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Changchun Institute of Biological Products

Establishment time : 1958

website : http://www.cibp.cdic.com.cn/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. With a history dating back to 1958, the company has grown to become a key player in the industry, serving both domestic and international markets with high-quality and innovative products. With a large production capacity and a strong competitive position, Changchun Institute of Biological Products continues to make significant contributions to public health and disease prevention worldwide.

Chengdu Institute of Biological Products

Establishment time : 1958

website : www.cdibp.com.cn

Main Product : Vaccines, blood products, biological drugs

Company Profile

Chengdu Institute of Biological Products (CDIBP) is a renowned biopharmaceutical company established in 1958. It specializes in the research, development, and production of vaccines, blood products, and biological drugs. With a large company size and a strong presence in both domestic and international markets, CDIBP is a leading manufacturer in China and a key player in the global biopharmaceutical industry. Visit their website at www.cdibp.com.cn for more information.

Beijing Tiantan Biological Products Co., Ltd.

Establishment time : 1992

website : http://www.btbio.com.cn/

Main Product : Vaccines, blood products, diagnostic reagents

Company Profile

Beijing Tiantan Biological Products Co., Ltd. is a well-established company specializing in the production of vaccines, blood products, and diagnostic reagents. With a large workforce and a strong presence in both domestic and international markets, the company is a leading player in the field of biological products. Established in 1992, the company has a reputation for high-quality products and a commitment to innovation in the healthcare industry. Visit their website for more information.

Wuhan Institute of Biological Products

Establishment time : 1967

website :

Main Product : Vaccines and biological products

Company Profile

Wuhan Institute of Biological Products is a leading manufacturer of vaccines and biological products in China. Established in 1967, the company has a medium-sized operation and primarily serves the domestic market. They face competition from other vaccine manufacturers in the country.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.

website :

Main Product : With a large company size, Kangtai has established a strong presence in the market.

Company Profile

Kangtai continues to expand its product portfolio and reach new markets to meet the growing demand for vaccines and biological products.

Hualan Biological Engineering Inc.

Establishment time : Hualan Biological Engineering Inc. was founded in 1992 and has since become a leading biotech company in China.

website :

Main Product : With a large company size, Hualan Biological Engineering Inc. has established itself as a key player in the biotech industry.

Company Profile

Hualan Biological Engineering Inc. continues to strive for excellence in the biotech field, focusing on improving healthcare and advancing medical technology.

Sinovac Biotech Ltd.

Establishment time : Sinovac Biotech Ltd. is a leading biopharmaceutical company in China.

website :

Main Product : Sinovac was founded in 1999 and has since become a major player in the global vaccine market.

Company Profile

Sinovac is committed to improving public health through the development of innovative vaccines and continues to expand its product portfolio to address emerging infectious diseases.

Shanghai Institute of Biological Products

Establishment time : Shanghai Institute of Biological Products (SIBP) was founded in 1957 and is a leading manufacturer of vaccines and biological products in China.

website :

Main Product : SIBP is known for its high-quality vaccines that meet international standards and are widely used in disease prevention and control programs.

Company Profile

Overall, Shanghai Institute of Biological Products is a reputable and reliable company that plays a crucial role in promoting public health through its quality vaccines and biological products.

The above is the China Top 10 Human Anti Rabies Vaccine Brands we have listed for you. You can submit the following form to obtain more industry information we provide for you.

You can visit our website or contact us, and we will provide the latest consultation and solutions

Share to:

Send Inquiry

Home> Industry Information> China Top 10 Human Anti Rabies Vaccine Brands
We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send